p27-V109G Polymorphism Is Not Associated with the Risk of Prostate Cancer: A Case-Control Study of Han Chinese Men in Central China

Table 4

p27-V109G polymorphism and clinic pathological characteristics in Chinese patients with PCa.

Group	TT (%)	TG/GG (%)	value^a	OR (95% CI)	OR (95% CI)^b
Clinical^c			0.161	0.222 (0.027–1.816)	—
Localized	56	12
Advanced	21	1
Gleason			0440	1.600 (0.453–5.652)	1.651 (0.463–5.890)
>7	32	4
≤7	45	9
Total PSA (ng/ml)			0.972	0.875 (0.269–2.848)	0.978 (0.290–3.296)
>20	33	6
≤20	44	7

^aTwo-sided χ² test for the distributions between TT and TT/GG; ^badjusting for age and body mass index (BMI); ^clocalized, T1–2N0M0; advanced, T3–4NxMx or TxN1Mx or TxNxM1. Clinical staging according to the international TNM system for prostate cancer.